Global Facial Injectables Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Facial Injectables Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Type (Wrinkle Relaxers (Botulinum Toxin), Dermal Fillers (Collagen, Hyaluronic Acid, Fat Injection, Polylactic Acid, Polymethyl-methacrylate Microspheres (PMMA), Calcium Hydroxylapatite, and Other Dermal Fillers (Polyalkylimide, etc.)), Application (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, and Other Applications (Chin augmentation and Earlobe Rejuvenation etc.)), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Facial Injectables Market was valued at USD 11,515.8 million in 2023 and is expected to reach USD 28,717.0 million by 2031 while growing at a CAGR of 12.1% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global facial injectables market growth. Facial injectables, a category of cosmetic procedures, involve injecting substances into the skin or underlying tissues to enhance facial features, reduce wrinkles, and rejuvenate the skin. Widely used in aesthetic medicine, they address signs of aging, improve facial contours, and yield a more youthful appearance. The two primary types are dermal fillers and neurotoxins.
Advancements in technology, specifically in facial injectables, and increasing awareness of cosmetic procedures are driving the facial injectables market. However, stringent regulatory requirements, approval processes, and the availability of non-invasive alternatives may impede market expansion.
Furthermore, the global facial injectables industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Type Analysis
The Global Facial Injectables Market is segmented among Wrinkle Relaxers, and Dermal Fillers, based on Type. In 2023, Wrinkle Relaxers accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Application Analysis
The Global Facial Injectables Market is segmented among Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, and Other Applications, based on Application. In 2023, Facial Line Correction accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Facial Injectables Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are AbbVie Inc (Allergan Plc), Anika Therapeutics Inc., Ipsen SA, Medytox Inc., Merz Pharma, Galderma Pharma SA, Sanofi SA, Sinclair Pharma Plc, Suneva Medical Inc., and Alphaeon Corporation (Teoxane Laboratories).
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Facial Injectables Market Dynamics
Drivers
Restraints
Opportunity
4. Global Facial Injectables Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Facial Injectables Market Segmentation, By Type
Global Facial Injectables Market Share Analysis, By Type
Global Facial Injectables Market Growth Analysis, By Type
Global Facial Injectables Market Trends, By Type
o Wrinkle Relaxers
Ø Botulinum Toxin
o Dermal Fillers
Ø Collagen
Ø Hyaluronic Acid
Ø Fat Injection
Ø Polylactic Acid
Ø Polymethyl-methacrylate Microspheres (PMMA)
Ø Calcium Hydroxylapatite
Ø Other Dermal Fillers (Polyalkylimide etc.)
6. Global Facial Injectables Market Segmentation, By Application
Global Facial Injectables Market Share Analysis, By Application
Global Facial Injectables Market Growth Analysis, By Application
Global Facial Injectables Market Trends, By Application
o Facial Line Correction
o Lip Augmentation
o Face Lift
o Acne Scar Treatment
o Lipoatrophy Treatment
o Other Applications
7. Global Facial Injectables Market Segmentation, By Region
Global Facial Injectables Market Share Analysis, By Region
Global Facial Injectables Market Growth Analysis, By Region
Global Facial Injectables Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
8. Competitive Landscape
AbbVie Inc (Allergan Plc)*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Anika Therapeutics Inc.
Ipsen SA
Medytox Inc.
Merz Pharma
Galderma Pharma SA
Sanofi SA
Sinclair Pharma Plc
Suneva Medical Inc.
Alphaeon Corporation (Teoxane Laboratories)
*Similar analysis will be provided for each company listed above.